{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:59:14Z","timestamp":1785578354486,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.arbres.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:10:35Z","timestamp":1776575435000},"page":"542-547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Minimal Important Difference of FEV1 and FVC in COPD Patients Undergoing Bronchoscopic Lung Volume Reduction"],"prefix":"10.1016","volume":"62","author":[{"given":"Jorine E.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Caspar Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klooster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk-Jan","family":"Slebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2026.04.003_bib0165","series-title":"GOLD report","first-page":"2025","year":"2025"},{"key":"10.1016\/j.arbres.2026.04.003_bib0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0175","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.arbres.2026.04.003_bib0180","first-page":"111","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2026.04.003_bib0185","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201607-1383OC","article-title":"Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study","volume":"194","author":"Valipour","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0190","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1164\/rccm.201707-1327OC","article-title":"A Multicenter RCT of Zephyr\u00ae endobronchial valve treatment in heterogeneous emphysema (TRANSFORM)","volume":"196","author":"Kemp","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0195","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201803-0590OC","article-title":"A Multicenter RCT of Zephyr\u00ae endobronchial valve treatment in heterogeneous emphysema (LIBERATE)","volume":"198","author":"Criner","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0200","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa1507807","article-title":"Endobronchial valves for emphysema without interlobar collateral ventilation","volume":"373","author":"Klooster","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1183\/09031936.00015312","article-title":"Radiological and clinical outcomes of using ChartisTM to plan endobronchial valve treatment","volume":"41","author":"Herth","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0215","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(11)61050-7","article-title":"Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial","volume":"378","author":"Shah","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2026.04.003_bib0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000362522","article-title":"Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial","volume":"88","author":"Klooster","year":"2014","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2026.04.003_bib0225","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1378\/chest.11-0730","article-title":"Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema","volume":"142","author":"Slebos","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.04.003_bib0230","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/thoraxjnl-2014-205221","article-title":"Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial","volume":"69","author":"Deslee","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2026.04.003_bib0235","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update an official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0245","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01519-2022","article-title":"European Respiratory Society\/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update","volume":"62","author":"Bhakta","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0250","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0260","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.arbres.2026.04.003_bib0265","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1183\/09031936.00063810","article-title":"The minimal important difference of exercise tests in severe COPD","volume":"37","author":"Puhan","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0270","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1183\/13993003.00535-2015","article-title":"The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD","volume":"46","author":"Welling","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.04.003_bib0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jclinepi.2009.01.024","article-title":"The minimal detectable change cannot reliably replace the minimal important difference","volume":"63","author":"Turner","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.arbres.2026.04.003_bib0280","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2014.13128","article-title":"Minimal clinically important difference: defining what really matters to patients","volume":"312","author":"McGlothlin","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.arbres.2026.04.003_bib0285","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.arbres.2026.04.003_bib0290","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1164\/rccm.202303-0400SO","article-title":"An update on outcomes for COPD pharmacological trials: a COPD investigators report \u2013 reassessment of the 2008 American Thoracic Society\/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials","volume":"208","author":"Cazzola","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.04.003_bib0295","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pupt.2017.12.005","article-title":"Correlations between FEV1 and patient-reported outcomes: a pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease","volume":"49","author":"Donohue","year":"2018","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.arbres.2026.04.003_bib0300","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pupt.2008.04.005","article-title":"The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD","volume":"21","author":"Ben Saad","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.arbres.2026.04.003_bib0305","first-page":"55","article-title":"A model to predict residual volume from forced spirometry measurements in chronic obstructive pulmonary disease","volume":"10","author":"Evankovich","year":"2023","journal-title":"Chronic Obstr Pulm Dis"},{"key":"10.1016\/j.arbres.2026.04.003_bib0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2332\/allergolint.O-06-431","article-title":"Correlation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary disease","volume":"56","author":"Omata","year":"2007","journal-title":"Allergol Int"},{"key":"10.1016\/j.arbres.2026.04.003_bib0315","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.apmr.2009.10.017","article-title":"Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease","volume":"91","author":"Holland","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.arbres.2026.04.003_bib0320","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.00156410","article-title":"How important is a minimal difference?","volume":"37","author":"Troosters","year":"2011","journal-title":"Eur Respir J"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:27:41Z","timestamp":1785576461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0300289626001444"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.003","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimal Important Difference of FEV1 and FVC in COPD Patients Undergoing Bronchoscopic Lung Volume Reduction","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}